JP4190769B2 - Oral liquid composition - Google Patents
Oral liquid composition Download PDFInfo
- Publication number
- JP4190769B2 JP4190769B2 JP2002027757A JP2002027757A JP4190769B2 JP 4190769 B2 JP4190769 B2 JP 4190769B2 JP 2002027757 A JP2002027757 A JP 2002027757A JP 2002027757 A JP2002027757 A JP 2002027757A JP 4190769 B2 JP4190769 B2 JP 4190769B2
- Authority
- JP
- Japan
- Prior art keywords
- liquid composition
- taste
- internal
- fruit
- stevia extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007788 liquid Substances 0.000 title claims description 43
- 239000000203 mixture Substances 0.000 title claims description 31
- 235000019640 taste Nutrition 0.000 claims description 34
- 244000228451 Stevia rebaudiana Species 0.000 claims description 20
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 19
- 239000003205 fragrance Substances 0.000 claims description 19
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 13
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 13
- 229960004998 acesulfame potassium Drugs 0.000 claims description 13
- 239000000619 acesulfame-K Substances 0.000 claims description 13
- 235000003599 food sweetener Nutrition 0.000 claims description 13
- 239000003765 sweetening agent Substances 0.000 claims description 13
- 235000013305 food Nutrition 0.000 claims description 12
- 239000004480 active ingredient Substances 0.000 claims description 11
- 239000008369 fruit flavor Substances 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- 229930003270 Vitamin B Natural products 0.000 claims description 6
- 235000019156 vitamin B Nutrition 0.000 claims description 6
- 239000011720 vitamin B Substances 0.000 claims description 6
- 241000207199 Citrus Species 0.000 claims description 4
- 244000070406 Malus silvestris Species 0.000 claims description 4
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 4
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 4
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 4
- 230000001754 anti-pyretic effect Effects 0.000 claims description 4
- 239000002221 antipyretic Substances 0.000 claims description 4
- 235000020971 citrus fruits Nutrition 0.000 claims description 4
- 235000013373 food additive Nutrition 0.000 claims description 4
- 239000002778 food additive Substances 0.000 claims description 4
- 241000411851 herbal medicine Species 0.000 claims description 4
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 3
- 230000000954 anitussive effect Effects 0.000 claims description 3
- 239000000739 antihistaminic agent Substances 0.000 claims description 3
- 229940124584 antitussives Drugs 0.000 claims description 3
- 239000003172 expectorant agent Substances 0.000 claims description 3
- 230000003419 expectorant effect Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims description 2
- 230000000202 analgesic effect Effects 0.000 claims description 2
- 230000001387 anti-histamine Effects 0.000 claims description 2
- 229940124579 cold medicine Drugs 0.000 claims description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 230000002439 hemostatic effect Effects 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 235000019645 odor Nutrition 0.000 description 15
- -1 analgesic Substances 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 11
- 239000002904 solvent Substances 0.000 description 10
- 235000019658 bitter taste Nutrition 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 235000019606 astringent taste Nutrition 0.000 description 6
- 235000015165 citric acid Nutrition 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 229940100688 oral solution Drugs 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 6
- 239000004299 sodium benzoate Substances 0.000 description 6
- 235000010234 sodium benzoate Nutrition 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 206010013911 Dysgeusia Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 241000286209 Phasianidae Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000219095 Vitis Species 0.000 description 3
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000000375 suspending agent Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 241001071795 Gentiana Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 230000001741 anti-phlogistic effect Effects 0.000 description 2
- 229940030225 antihemorrhagics Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- 229960002104 cyanocobalamin Drugs 0.000 description 2
- 235000000639 cyanocobalamin Nutrition 0.000 description 2
- 239000011666 cyanocobalamin Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000002874 hemostatic agent Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 239000010813 municipal solid waste Substances 0.000 description 2
- CPJSUEIXXCENMM-UHFFFAOYSA-N phenacetin Chemical compound CCOC1=CC=C(NC(C)=O)C=C1 CPJSUEIXXCENMM-UHFFFAOYSA-N 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- RPYRMTHVSUWHSV-CUZJHZIBSA-N rebaudioside D Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RPYRMTHVSUWHSV-CUZJHZIBSA-N 0.000 description 2
- QSRAJVGDWKFOGU-WBXIDTKBSA-N rebaudioside c Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]1(CC[C@H]2[C@@]3(C)[C@@H]([C@](CCC3)(C)C(=O)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)CC3)C(=C)C[C@]23C1 QSRAJVGDWKFOGU-WBXIDTKBSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- UHSXRTHJCJGEKG-UQKRIMTDSA-N (1s)-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-ium-6,7-diol;chloride Chemical compound Cl.COC1=C(OC)C(OC)=CC(C[C@H]2C3=CC(O)=C(O)C=C3CCN2)=C1 UHSXRTHJCJGEKG-UQKRIMTDSA-N 0.000 description 1
- AJZJIYUOOJLBAU-CEAXSRTFSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;n,n,2-trimethyl-3-phenothiazin-10-ylpropan-1-amine Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1=CC=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1.C1=CC=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1 AJZJIYUOOJLBAU-CEAXSRTFSA-N 0.000 description 1
- YQSHYGCCYVPRDI-UHFFFAOYSA-N (4-propan-2-ylphenyl)methanamine Chemical compound CC(C)C1=CC=C(CN)C=C1 YQSHYGCCYVPRDI-UHFFFAOYSA-N 0.000 description 1
- DBOVHQOUSDWAPQ-UHFFFAOYSA-N (4aS)-6c-[O2-(3,5,3'-trihydroxy-biphenyl-2-carbonyl)-beta-D-glucopyranosyloxy]-5t-vinyl-(4ar)-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one Natural products OC1C(O)C(CO)OC(OC2C(C3C(C(OCC3)=O)=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-UHFFFAOYSA-N 0.000 description 1
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical group CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NVKQKAZYUPPRJX-UHFFFAOYSA-N 1,3,5-tribromo-2-(2,5-dibromophenyl)benzene Chemical compound BrC1=CC=C(Br)C(C=2C(=CC(Br)=CC=2Br)Br)=C1 NVKQKAZYUPPRJX-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- BZXINCMCFVKGKB-UHFFFAOYSA-N Amarogentin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cc(O)cc(O)c4c5cccc(O)c5)C(O)C1O BZXINCMCFVKGKB-UHFFFAOYSA-N 0.000 description 1
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 1
- 244000296825 Amygdalus nana Species 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 241000269837 Artemisia dubia Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241001106067 Atropa Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241001416153 Bos grunniens Species 0.000 description 1
- GPXJKVFRKZAYCC-LBPRGKRZSA-N Calacone Natural products O=C1[C@@H](C)CCC(C(C)C)=C1CCC(=C)C GPXJKVFRKZAYCC-LBPRGKRZSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 244000025596 Cassia laevigata Species 0.000 description 1
- 235000006693 Cassia laevigata Nutrition 0.000 description 1
- 241000501711 Centaurium Species 0.000 description 1
- 241000258920 Chilopoda Species 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 241000544061 Cuculus canorus Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 239000001776 FEMA 4720 Substances 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 241000555712 Forsythia Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 244000255365 Kaskarillabaum Species 0.000 description 1
- 244000108452 Litchi chinensis Species 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 235000014196 Magnolia kobus Nutrition 0.000 description 1
- 240000005378 Magnolia kobus Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 241000581835 Monodora junodii Species 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 235000015742 Nephelium litchi Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 241001527087 Panax vietnamensis Species 0.000 description 1
- 235000017726 Panax vietnamensis Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 244000288157 Passiflora edulis Species 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 235000010913 Picrasma quassioides Nutrition 0.000 description 1
- 240000004659 Picrasma quassioides Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- RLLCWNUIHGPAJY-RYBZXKSASA-N Rebaudioside E Natural products O=C(O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)[C@@H](O)[C@@H](O)[C@H](CO)O1)[C@]1(C)[C@@H]2[C@@](C)([C@@H]3[C@@]4(CC(=C)[C@@](O[C@@H]5[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O6)[C@H](O)[C@@H](O)[C@H](CO)O5)(C4)CC3)CC2)CCC1 RLLCWNUIHGPAJY-RYBZXKSASA-N 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- OHSHFZJLPYLRIP-BMZHGHOISA-M Riboflavin sodium phosphate Chemical compound [Na+].OP(=O)([O-])OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O OHSHFZJLPYLRIP-BMZHGHOISA-M 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 241001593968 Vitis palmata Species 0.000 description 1
- 241001222097 Xenocypris argentea Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- NTCYWJCEOILKNG-ROLPUNSJSA-N [(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]-dimethylazanium;chloride Chemical compound Cl.CN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1 NTCYWJCEOILKNG-ROLPUNSJSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- JUGOREOARAHOCO-UHFFFAOYSA-M acetylcholine chloride Chemical compound [Cl-].CC(=O)OCC[N+](C)(C)C JUGOREOARAHOCO-UHFFFAOYSA-M 0.000 description 1
- 229960004266 acetylcholine chloride Drugs 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- BNPSSFBOAGDEEL-UHFFFAOYSA-N albuterol sulfate Chemical compound OS(O)(=O)=O.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 BNPSSFBOAGDEEL-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- WLDHEUZGFKACJH-UHFFFAOYSA-K amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1N=NC1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-UHFFFAOYSA-K 0.000 description 1
- DBOVHQOUSDWAPQ-WTONXPSSSA-N amarogentin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-WTONXPSSSA-N 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229950008138 carmellose Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical group [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 229960004415 codeine phosphate Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229960003596 cyproheptadine hydrochloride Drugs 0.000 description 1
- ZPMVNZLARAEGHB-UHFFFAOYSA-N cyproheptadine hydrochloride (anhydrous) Chemical compound Cl.C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 ZPMVNZLARAEGHB-UHFFFAOYSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229960003782 dextromethorphan hydrobromide Drugs 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 229960001193 diclofenac sodium Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229960000920 dihydrocodeine Drugs 0.000 description 1
- HFBYLYCMISIEMM-FFHNEAJVSA-N dihydrocodeine phosphate Chemical compound OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC HFBYLYCMISIEMM-FFHNEAJVSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229940120889 dipyrone Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 229960002534 ephedrine hydrochloride Drugs 0.000 description 1
- 229960003072 epinephrine hydrochloride Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229960002146 guaifenesin Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- LZULAZTXJLWELL-UHFFFAOYSA-N methyl hex-5-ynoate Chemical compound COC(=O)CCCC#C LZULAZTXJLWELL-UHFFFAOYSA-N 0.000 description 1
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 description 1
- 235000007672 methylcobalamin Nutrition 0.000 description 1
- 239000011585 methylcobalamin Substances 0.000 description 1
- 229940051020 methylephedrine hydrochloride Drugs 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000010330 ougon Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 229960005301 pentazocine Drugs 0.000 description 1
- VOKSWYLNZZRQPF-GDIGMMSISA-N pentazocine Chemical compound C1C2=CC=C(O)C=C2[C@@]2(C)[C@@H](C)[C@@H]1N(CC=C(C)C)CC2 VOKSWYLNZZRQPF-GDIGMMSISA-N 0.000 description 1
- 229960003893 phenacetin Drugs 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229960002789 procaterol hydrochloride Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- RLLCWNUIHGPAJY-SFUUMPFESA-N rebaudioside E Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RLLCWNUIHGPAJY-SFUUMPFESA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 229940048730 senega Drugs 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 108010021724 tonin Proteins 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
【0001】
【発明の属する技術分野】
本発明は、内服液組成物に関し、更に詳述すると、配合される医薬食品有効成分の有する苦味、渋味、エグ味等の不快な味及び独特の不快な臭いを改善し、服用を容易にすることができる内服液組成物に関する。
【0002】
【従来の技術】
従来から、内服液剤は、服用の容易さから、これまで数多くの製品が開発され、広く実用化されてきている。この場合、内服液剤に配合する医薬食品有効成分の不快な呈味を改善したり、独特の臭いをマスキングするため、香料や蔗糖等の甘味剤を配合することが行われており、ある程度の呈味改善や臭いのマスキングが図られている。
【0003】
しかしながら、依然として美味しく服用するという程度まで呈味や臭いを改善することは困難であった。このため、疾患を有する患者が、本来連用しなければならない医薬品の服用を途中でやめたり、小児が医薬品を吐き出したりすることで必要量が摂取できず、病気回復の遅延や疾患の悪化が生じるという問題があり、更なる改善が強く望まれている。
【0004】
【発明が解決しようとする課題】
本発明は、前記従来における諸問題を解決し、以下の目的を達成することを課題とする。
即ち、本発明は、苦味等の不快な呈味や独特の不快な臭いを有する医薬食品有効成分を配合した内服液を連用しても、美味しく服用でき、小児に服用させても内服液の有する異味・異臭によって、吐き出してしまうことのない呈味及び臭いが改善された内服液組成物を提供することを目的とする。
【0005】
【課題を解決するための手段】
本発明者らは、前記課題を解決するため、種々の甘味料と香料を組み合わせて鋭意検討を重ねた結果、(a)不快な味や臭いを有する医薬食品有効成分と、(b)フルーツ系香料と、(c)アセスルファムカリウムとステビア抽出物とを一定割合で配合した甘味料と、を組み合わせることにより、これら各成分の相乗効果から、呈味質、風味、あと味等が極めて良好な内服液組成物が得られることを見出し、本発明を完成するに至った。
【0006】
即ち、本発明は、前記課題を解決するため、下記の内服液組成物を提供することを目的とする。
【0007】
請求項1の発明は、(a)不快な味や臭いを有する医薬食品有効成分と、
(b)フルーツ系香料と、
(c)アセスルファムカリウムとステビア抽出物とを、質量比で、アセスルファムカリウム:ステビア抽出物=10:1〜4となるように配合した甘味料と、
を含有することを特徴とする内服液組成物である。
請求項2の発明は、(a)成分の医薬食品有効成分が、かぜ薬、解熱剤、鎮痛剤、消炎剤、鎮咳剤、去痰剤、抗ヒスタミン剤、止血剤、生薬、ビタミンB群類及び食品添加物から選ばれる1種又は2種以上である請求項1に記載の内服液組成物である。
請求項3の発明は、(b)成分のフルーツ系香料が、カンキツ系香料、ブドウ系香料、プルナス属果実系香料及びリンゴ系香料からなる群より選ばれる1種又は2種以上である請求項1又は2に記載の内服液組成物である。
請求項4の発明は、(c)成分の甘味料を内服液組成物全量に対し0.005〜0.3W/V%配合する請求項1乃至3のいずれかに記載の内服液組成物である。
請求項5の発明は、pHが2〜5である請求項1乃至4のいずれかに記載の内服液組成物である。
【0008】
本発明によれば、苦味、渋味、エグ味を有する不快な呈味の医薬食品有効成分に対して、甘味の早く発現するアセスルファムカリウムが、早く発現する苦味等をマスキングする一方、甘味が後に残るステビア抽出物が服用後遅く発現する渋味、エグ味を抑えることで呈味が改善すると共に、フルーツ系香料が医薬食品有効成分の不快臭をマスキングし得、これらの相乗効果によって、極めて服用感の良好な呈味を有するようになる。
【0009】
また、内服液組成物にステビア抽出物が配合されない場合には、フルーツ系香料の不快感マスキングが十分でなく、ステビア抽出物は、フレーバーエンハンサー(味・臭いの相乗改善剤)としても働いているものと推定される。
【0010】
【発明の実施の形態】
以下、本発明について更に詳しく説明する。
本発明の内服液組成物は、(a)不快な味や臭いを有する医薬食品有効成分と、(b)フルーツ系香料と、(c)アセスルファムカリウム及びステビア抽出物からなる甘味料と、を含有し、必要に応じてその他の成分を含有する。
【0011】
前記(a)成分の苦味、渋味、エグ味等の不快な味や独特の不快な臭いを有する医薬食品有効成分としては、かぜ薬、解熱剤、鎮痛剤、消炎剤、鎮咳剤、去痰剤、抗ヒスタミン剤、止血剤等の医薬品、生薬、ビタミンB群類、食品添加物などが挙げられ、これらは1種を単独で又は2種以上を組み合わせて用いることができる。
【0012】
前記医薬品としては、例えば、アセトアミノフェン、アスピリン、フェナセチン、メフェナム酸、アンチピリン、フェニルブタゾン、スルピリン、ジクロフェナクナトリウム、イブプロフェン、ケトプロフェン、ナプロキセン、エピリゾール、塩酸チアラミド、インドメタシン、ペンタゾシン、塩化アセチルコリン、酒石酸アリメマジン、塩酸シプロヘプタジン、ジフェンヒドラミン、塩酸ジフェンヒドラミン、マレイン酸クロルフェニラミン、リン酸コデイン、リン酸ジヒドロコデイン、臭化水素酸デキストロメトルファン、クエン酸ペントキシベリン、テオフィリン、アミノフィリン、塩酸エフェドリン、塩酸エピネフリン、硫酸サルブタモール、塩酸トリメトキノール、塩酸プロカテロール、塩酸メチルエフェドリン、塩酸フェニルプロパノールアミン、グアイフェネシン、トラネキサム酸、無水カフェイン、カフェインなどが挙げられ、これらは1種単独で使用してもよく、2種以上を併用してもよい。
【0013】
前記生薬としては、例えば、アロエ、ウイキョウ、ウコン、ウヤク、エンゴサク、エイジツ、オウギ、オウセイ、オンジ、ガラナ、クコシ、ジオウ、トウキ、トチュウ、ニンジン、アマロゲンチン、オウゴン、オウバク、オウレン、ガジュツ、カスカラサグラダ、カッコウ、カスカリラノキ、カノコ草、カロウコン、キキョウ、キジツ、キョウニン、キハダ、クコ、クジン、ケイガイ、ケイヒ、ケツメイシ、ケンゴシ、ゲンチアナ、ゲンノショウコ、コウジン、コウブシ、コウボク、ゴオウ、ゴシツ、ゴシュユ、ゴミシ、コロンボ、コンズランゴ、サイコ、サンシシ、サフラン、サンズコン、ジオウ、シコン、シソシ、シャクヤク、シャジン(ツリガネニンジン)、シャゼン(オオバコ)、ジャ香、ショウキョウ、ショウマ、セイヒ、セキショウコン、センキュウ、センコツ、センタウリウム草、センブリ、センボウ、センソ、センナ、ソウジュツ、ソウハクヒ、ソヨウ、ダイオウ、竹節人参、チモ、チレッタ草、チンピ、トウヒ、トウニン、トコン、ニガキ、ニンジン、ビャクシャク、ビャクジュツ、ベラドンナコン、ヘノポジ油、ヤクチ、ユウタン、ヨモギ、ニガヨモギ、苦味チンキ、ジシュユ、ホップ、ホミカ、ボウイ、マオウ、モクツウ、モッコウ、リュウタン、リンドウ、ルソンカ、レンギョウ、ニンジン、セネガ、キキョウ、ショウキョウ、ローヤルゼリーなどが挙げられ、これらは1種単独で使用してもよく、2種以上を併用してもよい。
【0014】
前記ビタミンB群類としては、例えば、ビタミンB1群(例えば、チアミン、硝酸チアミン、塩酸チアミン、ビタミンB1誘導体等)、ビタミンB2群(例えば、リボフラビン、リン酸リボフラビンナトリウム、酪酸リボフラビン等)、ビタミンB6群(例えば、ピリドキシン、ピリドキサル、ピリドキサミン及びこれらのリン酸あるいは塩酸塩等)、ビタミンB12群(例えば、コバラミン、シアノコバラミン、メチルコバラミン等)などが挙げられ、これらは1種単独で使用してもよく、2種以上を併用してもよい。
【0015】
前記食品添加物としては、例えば、パントテン酸カルシウム、塩化カリウム、蠣殻末、ナイアシンアミド、ビオチン、海藻粉末、ニコチン酸アミド、シアノコバラミンなどが挙げられ、これらは1種単独で使用してもよく、2種以上を併用してもよい。
【0016】
前記(a)成分の不快な味や臭いを有する医薬食品有効成分は、それぞれの目的に応じて薬効を奏する有効量の範囲で配合されるが、通常、内服液組成物全量に対し0.001〜1W/V%配合することが好ましい。
【0017】
前記(b)成分のフルーツ系香料としては、例えば、ミカン、オレンジ、レモン、グレープフルーツ、シークアーサー等のカンキツ系香料、赤ブドウ、マスカット等のブドウ系香料、モモ、アプリコット、ウメ、アンズ等のプルナス属果実香料、青リンゴ等のリンゴ系香料、パッションフルーツ、パイナップル、ライチ、バナナ等のトロピカルフルーツ系香料、イチゴ系香料などが挙げられ、これらは、1種のみで配合しても良く、2種以上配合することもできる。これらの中でも、カンキツ系香料、ブドウ系香料、プルナス属果実系香料、リンゴ系香料が風味の改善が好適である点で特に好ましい。
【0018】
前記(b)成分のフルーツ系香料は、内服液組成物全量に対し、0.001〜1.0W/V%配合することが好ましく、0.05〜0.5W/V%配合することがより好ましい。
【0019】
前記(c)成分の甘味料は、ステビア抽出物とアセスルファムカリウムとを混合してなる。
ここで、前記アセスルファムカリウム及びステビア抽出物の配合比率は、質量比で、アセスルファムカリウム10に対し、ステビア抽出物が1〜4であり、特に1.5〜3であることが好ましい。ステビア抽出物が1未満の場合には、呈味の改善が十分ではなくなり、一方、4を超えると、ステビア抽出物の後甘味が強く出ることで、くどい甘味を呈し、服用感が悪くなる。
【0020】
前記(c)成分のステビア抽出物は、キク科の多年生植物ステビア(Stevia Rebaudiana)の葉を抽出精製して甘味成分の純度を80%以上にしたものであり、砂糖の300倍以上の甘味を有する天然甘味料である。
このステビア抽出物としては、ステビオサイド、レバウディオサイドA、レバウディオサイドC、レバウディオサイドD、レバウディオサイドE、ズルコサイドA単品及びこれらにグルコシルトランスフェラーゼを作用させて得られるα−グルコシル化合物も含まれる。
【0021】
前記(c)成分のアセスルファムカリウム〔6−メチル−1,2,3−オキサチアジン−4(3H)−オン−2,2−ジオキシドのカリウム塩(C4H4KNO4S、分子量:201.24)〕は、下記の構造式を有する合成甘味料であり、5%蔗糖水溶液と比較したとき蔗糖の約200倍の甘味度を有する。
【0022】
【化1】
【0023】
前記(c)成分のアセスルファムカリウム及びステビア抽出物からなる甘味料は、内服液組成物中の不快な味や臭いを有する成分により、配合量を加減することもできるが、内服液組成物に対し、0.005〜0.3W/V%、好ましくは0.01〜0.15W/V%である。
前記アセスルファムカリウム及びステビア抽出物の配合量が0.005W/V%未満の場合は、呈味改善効果が十分でなくなり、一方、0.3W/V%を超えると、甘味が強すぎてくどい味となり、服用が困難となる場合がある。
【0024】
なお、本発明の内服液組成物の呈味改善効果を疎外しない程度であれば、(c)成分の甘味料以外にも、甘味のボリューム感を出すために、果糖、蔗糖、ブドウ糖、麦芽糖等の糖質甘味料を配合しても良く、更に甘味の爽快感を出すために、マルチトール、キシリトール、エリスリトール、ソルビトール、マンニトール等の糖アルコール類、アスパルテーム、シエクラロース、サッカリン等の高甘味度甘味料を配合しても良い。
【0025】
本発明の内服液組成物は、前記(a)〜(c)の必要成分を含むと共に、酸を用いて液性のpHを2〜5にし、酸味を強化することで、爽快感を強化して、より一層服用し易い呈味に改善することができる。
この場合、前記内服液組成物のpHを2〜5に調整するためには、pH調整剤として、例えば、酢酸、クエン酸、リンゴ酸、酒石酸、アスコルビン酸等の有機酸やリン酸を用いることが好ましい。
【0026】
前記その他の成分としては、特に制限はなく、目的に応じて適宜選定することができるが、例えば、防腐剤、保存剤、着香剤、芳香剤、清涼化剤、界面活性剤、可溶化剤、乳化剤、溶剤、緩衝剤、懸濁剤、粘稠剤、着色剤、安定化剤、溶解補助剤などが挙げられ、これらは1種単独で使用してもよく、2種以上を併用してもよい。
【0027】
前記防腐剤、保存剤としては、例えば、ソルビン酸ナトリウム、安息香酸類(安息香酸、安息香酸ナトリウム等)、パラベン類(パラオキシ安息香酸エチル、パラオキシ安息香酸ブチル、パラオキシ安息香酸プロピル等)などが挙げられる。
【0028】
前記界面活性剤、可溶化剤、乳化剤、及び、溶剤としては、例えば、ショ糖脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油類、ポリソルベート類及びプルロニック類等の非イオン性界面活性剤、エタノール、注射用蒸留水、精製水などが挙げられる。
【0029】
前記懸濁剤、粘稠剤としては、例えば、アラビアゴム、結晶セルロース、ビーガム、キサンタンガム、ゼラチン、メトロース及びその可食性塩、カルメロース及びその可食性塩などが挙げられる。
前記着色剤としては、例えば、カラメル、β−カロチン、各種食用色素(食用黄色1号、食用赤色2号等)などが挙げられる。
前記安定化剤としては、例えば、エデト酸の可食性塩、塩化ナトリウム、及び、ピロ亜硫酸の可食性塩などが挙げられる。
【0030】
前記その他の成分(防腐剤、保存剤、着香剤、芳香剤、清涼化剤、界面活性剤、可溶化剤、乳化剤、溶剤、緩衝剤、懸濁剤、粘稠剤、着色剤、安定化剤、及び、溶解補助剤等)の、内服液組成物における含有量としては、特に制限はなく、従来の経口液剤に配合される量で適宜含有されるのが好ましい。
【0031】
前記内服液組成物の調製方法としては、特に制限はなく、通常、各成分と精製水等の溶剤の一部とを混合、溶解し、残りの溶剤を加えて液量を調製し、必要に応じて、酸又はアルカリを用いてpHを調整する。
【0032】
本発明の内服液組成物は、液状形態で経口投与される医薬品、医薬部外品、健康食品であればよく、液剤(例えばシロップ剤、ドリンク剤)、懸濁剤、乳剤、顆粒剤、散剤、カプセル剤などに製剤化することができ、医薬用途としては、滋養強壮剤、感胃用剤、解熱鎮痛剤、気管支拡張剤等、内服液剤の形で用いられるものに適用できる。
【0033】
【実施例】
以下、実施例を挙げて、本発明を更に具体的に説明するが、本発明は、下記実施例に何ら限定されるものではない。
【0034】
〔実施例1〕 内服液剤
下記表1に示す成分と、精製水とポリオキシ硬化ヒマシ油と安息香酸ナトリウムとを加え、更にクエン酸でpHを3.4に調整した後100mLとして、本発明品1〜2及び比較品1〜4の内服液剤を製造した。
【0035】
次に、各内服液剤について、パネラー17名による、▲1▼苦味・渋味・エグ味、▲2▼後味の良さ、▲3▼前味の良さ、▲4▼独特の不快感、の4項目についての官能評価を下記評価基準に従って行い、評価結果の平均値を算出した。結果を表1に示す。
【0036】
<評価基準>
5点:優れる
4点:やや優れる
3点:普通
2点:やや劣る
1点:劣る
【0037】
【表1】
【0038】
〔実施例2〕 内服シロップ
下記表2に示す成分と、精製水とポリオキシエチレン硬化ヒマシ油と安息香酸ナトリウムを加え、更にクエン酸でpHを調整して100mLとして、本発明品3〜4及び比較品5〜7の内服シロップを製造した。
【0039】
次に、各内服シロップについて、パネラー18名による、▲1▼苦味・渋味・エグ味、▲2▼後味の良さ、▲3▼前味の良さ、▲4▼独特の不快感、の4項目についての官能評価を上記実施例1と同様に行い、評価結果の平均値を算出した。結果を表2に示す。
【0040】
【表2】
【0041】
〔実施例3〕 内服液剤
下記表3に示す成分と、ポリオキシエチレン硬化ヒマシ油と安息香酸ナトリウムと精製水を加え、更にクエン酸でpHを3.5に調整し、実施例3の内服液剤50mLを得た。
【0042】
【表3】
【0043】
〔実施例4〕 内服液剤
下記表4に示す成分と、プロピレングリコールと安息香酸ナトリウムと精製水を加え、更にクエン酸でpHを4とし、実施例4の内服液剤50mLを得た。
【0044】
【表4】
【0045】
〔実施例5〕 内服液剤
下記表5に示す成分と、ポリオキシエチレン硬化ヒマシ油と安息香酸ナトリウムと精製水を加え、更にクエン酸でpHを3.2に調整し、実施例5の内服液剤30mLを得た。
【0046】
【表5】
【0047】
上記実施例3〜5の内服液剤は、いずれも医薬食品有効成分の苦味等の不快な呈味や独特の不快な臭いが抑えられ、美味しく服用できるものであった。
【0048】
【発明の効果】
以上説明したように、本発明によれば、苦味等の不快な呈味や独特の不快な臭いを有する医薬食品有効成分を配合した内服液を連用しても、美味しく服用でき、小児に服用させても内服液の有する異味・異臭によって、吐き出してしまうということのない呈味及び臭いの改善された内服液組成物が得られる。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to an internal use liquid composition. More specifically, the present invention improves the unpleasant taste and unique unpleasant smell such as bitterness, astringency, and savory taste of the active pharmaceutical ingredient to be blended, and makes it easy to take. The present invention relates to a liquid composition for internal use.
[0002]
[Prior art]
Conventionally, a large number of products for internal use liquid preparations have been developed and widely put into practical use because of their ease of taking. In this case, sweeteners such as fragrances and sucrose have been added to improve the unpleasant taste of the active ingredients of pharmaceutical foods to be blended into the oral solution and mask unique odors. Taste improvement and odor masking are planned.
[0003]
However, it has been difficult to improve taste and odor to the extent that they are still deliciously taken. For this reason, patients with illness cannot take the required amount because they stop taking medicines that should be used continuously, or children expel medicines, resulting in delayed recovery of the disease and worsening of the disease. Therefore, further improvement is strongly desired.
[0004]
[Problems to be solved by the invention]
An object of the present invention is to solve the conventional problems and achieve the following objects.
That is, the present invention can be taken deliciously even if the internal liquid containing a pharmaceutical food active ingredient having an unpleasant taste such as a bitter taste or a unique unpleasant odor is used continuously. It is an object of the present invention to provide an internal liquid composition with improved taste and odor that will not be exhaled due to off-flavors and off-flavors.
[0005]
[Means for Solving the Problems]
In order to solve the above-mentioned problems, the present inventors have conducted extensive studies by combining various sweeteners and fragrances. As a result, (a) an active ingredient of a pharmaceutical food having an unpleasant taste and odor, and (b) a fruit system. A combination of a fragrance and (c) a sweetener containing acesulfame potassium and stevia extract in a certain ratio, so that the oral taste is excellent in taste, flavor, and aftertaste due to the synergistic effect of these components. The present inventors have found that a liquid composition can be obtained and have completed the present invention.
[0006]
That is, this invention aims at providing the following internal use liquid composition in order to solve the said subject.
[0007]
The invention of claim 1 includes: (a) an active pharmaceutical food ingredient having an unpleasant taste and odor;
(B) fruit flavors;
(C) a sweetener prepared by blending acesulfame potassium and stevia extract in a mass ratio such that acesulfame potassium: stevia extract = 10: 1 to 4,
It is an internal use liquid composition characterized by containing.
The invention of claim 2 is based on the fact that the active pharmaceutical ingredient of component (a) is a cold medicine, antipyretic, analgesic, antiphlogistic, antitussive, expectorant, antihistamine, hemostatic agent, herbal medicine, vitamin B group and food additive. It is 1 type, or 2 or more types chosen, It is an internal use liquid composition of Claim 1.
In the invention of claim 3, the fruit flavor of component (b) is one or more selected from the group consisting of citrus flavors, grape flavors, Purnas fruit flavors and apple flavors. The internal use liquid composition according to 1 or 2.
The invention of claim 4 is the internal liquid composition according to any one of claims 1 to 3, wherein the sweetener of component (c) is blended in an amount of 0.005 to 0.3 W / V% based on the total amount of the internal liquid composition. is there.
Invention of Claim 5 is an internal use liquid composition in any one of Claims 1 thru | or 4 whose pH is 2-5.
[0008]
According to the present invention, acesulfame potassium that expresses early sweetness masks bitterness that develops quickly, while sweetness is later on, for an unfavorable-tasting pharmaceutical food active ingredient having bitter taste, astringency, and egg taste. The remaining stevia extract improves taste by suppressing the astringent taste and egg taste that appear late after taking, and the fruit flavor can mask the unpleasant odor of active ingredients in pharmaceutical foods, and these synergistic effects can be taken extremely It has a good taste.
[0009]
Also, when stevia extract is not included in the oral liquid composition, the masking of discomfort of fruit flavors is not sufficient, and stevia extract also works as a flavor enhancer (synergistic improver of taste and smell) Estimated.
[0010]
DETAILED DESCRIPTION OF THE INVENTION
Hereinafter, the present invention will be described in more detail.
The internal liquid composition of the present invention contains (a) an active ingredient of a pharmaceutical food having an unpleasant taste and odor, (b) a fruit flavor, and (c) a sweetener comprising acesulfame potassium and stevia extract. In addition, other components are contained as necessary.
[0011]
The active ingredient of the pharmaceutical food having an unpleasant taste such as bitterness, astringency, egg taste, etc. or a unique unpleasant odor of the component (a) includes cold remedies, antipyretics, analgesics, antiphlogistics, antitussives, expectorants, antihistamines. , Pharmaceuticals such as hemostatic agents, herbal medicines, vitamin B groups, food additives, and the like, which can be used alone or in combination of two or more.
[0012]
Examples of the pharmaceuticals include acetaminophen, aspirin, phenacetin, mefenamic acid, antipyrine, phenylbutazone, sulpyrine, diclofenac sodium, ibuprofen, ketoprofen, naproxen, epilysole, tiaramid hydrochloride, indomethacin, pentazocine, acetylcholine chloride, alimemazine tartrate, Cyproheptadine hydrochloride, diphenhydramine, diphenhydramine hydrochloride, chlorpheniramine maleate, codeine phosphate, dihydrocodeine phosphate, dextromethorphan hydrobromide, pentoxyberine citrate, theophylline, aminophylline, ephedrine hydrochloride, epinephrine hydrochloride, salbutamol sulfate, hydrochloric acid Trimethoquinol, Procaterol hydrochloride, Methylephedrine hydrochloride, Phenyl chloride Panoruamin, guaifenesin, tranexamic acid, caffeine anhydrous, caffeine and the like, which may be used alone or in combination of two or more thereof.
[0013]
Examples of the herbal medicines include aloe, fennel, turmeric, yak, engosaku, ages, ogi, seisei, onji, guarana, kokushi, jiou, touki, eucommia, carrot, amarogentin, ougon, autaku, ouren, gajutsu, caskara sagrada , Cuckoo, cascarilla, cynomolgus grass, calacon, yellow pheasant, pheasant, yellow pheasant, yellowfin, wolfberry, kujin, kei gai, keihi, ketsumeishi, kengoshi, gentian, geno shouko, koujin, kobushi, koboku, burdock, gosh, goshyu, trash, goshyu, trash Conzurango, Psycho, Sanshishi, Saffron, Sandscon, Giant, Shikon, Shiso, Peonies, Shajin (Tsuriganeninjin), Shazen (Psyllium), Jasaka, Shokyo, Shouma, Sehi, Seki Turmeric, cucumber, centipede, centaurium grass, sea bream, senbou, senso, senna, sojutsu, sakuhakuhi, soyou, daiou, bamboo ginseng, chimo, chiletta grass, chimpi, spruce, tonin, tokon, nigaki, carrot, peony, beakjutsu, belladonna Kong, Henoposito oil, Yakuchi, Yuktan, Mugwort, Nigorimugi, Bitter tincture, Jishyu, Hop, Homika, Bowie, Maou, Mokutsu, Mokko, Ryutan, Gentian, Luzonka, Forsythia, Carrot, Senega, Kyojo, Kyojo, Royal Jelly, etc. These may be used alone or in combination of two or more.
[0014]
Examples of the vitamin B group include vitamin B group 1 (for example, thiamine, thiamine nitrate, thiamine hydrochloride, vitamin B 1 derivative, etc.), vitamin B group 2 (for example, riboflavin, sodium riboflavin phosphate, riboflavin butyrate, etc.) Vitamin B 6 group (for example, pyridoxine, pyridoxal, pyridoxamine and their phosphates or hydrochlorides), vitamin B 12 group (for example, cobalamin, cyanocobalamin, methylcobalamin, etc.) and the like. You may use, and may use 2 or more types together.
[0015]
Examples of the food additive include calcium pantothenate, potassium chloride, rice husk powder, niacinamide, biotin, seaweed powder, nicotinamide, cyanocobalamin and the like, and these may be used alone. Two or more kinds may be used in combination.
[0016]
The active ingredient of the pharmaceutical food having an unpleasant taste and smell of the component (a) is blended in an effective amount range having a medicinal effect according to each purpose, but is usually 0.001 with respect to the total amount of the oral liquid composition. It is preferable to blend ~ 1W / V%.
[0017]
Examples of the fruit flavor of the component (b) include citrus flavors such as mandarin oranges, lemons, grapefruits, and sea quasars, grape flavors such as red grapes and muscat, and prunus such as peaches, apricots, ume and apricots. Examples include genus fruit fragrances, apple-based fragrances such as green apples, passion fruit, pineapple, lychee, banana and other tropical fruit-based fragrances, strawberry-based fragrances, etc. The above can also be blended. Among these, citrus-based fragrances, grape-based fragrances, Prussian fruit-based fragrances, and apple-based fragrances are particularly preferable in terms of improving flavor.
[0018]
The fruit fragrance of the component (b) is preferably added in an amount of 0.001 to 1.0 W / V%, more preferably 0.05 to 0.5 W / V%, based on the total amount of the internal liquid composition. preferable.
[0019]
The sweetener of the said (c) component mixes a stevia extract and acesulfame potassium.
Here, the blending ratio of the acesulfame potassium and stevia extract is a mass ratio, and the stevia extract is 1 to 4 with respect to the acesulfame potassium 10, and preferably 1.5 to 3. When the stevia extract is less than 1, the taste is not sufficiently improved. On the other hand, when the stevia extract exceeds 4, the post-sweetness of the stevia extract is increased, resulting in a terrible sweetness and a poor feeling of taking.
[0020]
Stevia extract of component (c) is obtained by extracting and purifying the leaves of Stevia Rebaudiana from the asteraceae family to make the sweetness component more than 80% pure. It has a natural sweetener.
As this stevia extract, stevioside, rebaudioside A, rebaudioside C, rebaudioside D, rebaudioside E, zulcoside A alone and α-glucosyl obtained by allowing glucosyltransferase to act on them Also included are compounds.
[0021]
Acesulfame potassium of component (c) [6-methyl-1,2,3-oxathiazin-4 (3H) -one-2,2-dioxide potassium salt (C 4 H 4 KNO 4 S, molecular weight: 201.24) )] Is a synthetic sweetener having the following structural formula and has a sweetness of about 200 times that of sucrose when compared with a 5% sucrose aqueous solution.
[0022]
[Chemical 1]
[0023]
The sweetener consisting of acesulfame potassium and stevia extract as component (c) can be added or subtracted depending on the component having an unpleasant taste or odor in the internal liquid composition, but with respect to the internal liquid composition 0.005 to 0.3 W / V%, preferably 0.01 to 0.15 W / V%.
When the blended amount of acesulfame potassium and stevia extract is less than 0.005 W / V%, the taste improving effect is not sufficient, while when it exceeds 0.3 W / V%, the sweetness is too strong and the taste is harsh. It may become difficult to take.
[0024]
In addition to the sweetener of component (c), fructose, sucrose, dextrose, maltose, etc. in order to give a sense of sweetness as long as the taste improving effect of the oral liquid composition of the present invention is not marginalized High sugar sweeteners such as maltitol, xylitol, erythritol, sorbitol, mannitol, aspartame, sieclarose, saccharin, etc. May be blended.
[0025]
The internal use liquid composition of the present invention includes the necessary components (a) to (c) described above, and the acidity is enhanced by adjusting the liquid pH to 2 to 5 using an acid, thereby enhancing the refreshing feeling. Thus, the taste can be improved to be easier to take.
In this case, in order to adjust the pH of the internal liquid composition to 2 to 5, for example, an organic acid such as acetic acid, citric acid, malic acid, tartaric acid, ascorbic acid, or phosphoric acid is used as a pH adjuster. Is preferred.
[0026]
The other components are not particularly limited and may be appropriately selected depending on the purpose. For example, preservatives, preservatives, flavoring agents, fragrances, cooling agents, surfactants, solubilizers. , Emulsifiers, solvents, buffers, suspending agents, thickeners, colorants, stabilizers, solubilizers, and the like. These may be used alone or in combination of two or more. Also good.
[0027]
Examples of the preservative and preservative include sodium sorbate, benzoic acids (benzoic acid, sodium benzoate, etc.), parabens (ethyl paraoxybenzoate, butyl paraoxybenzoate, propyl paraoxybenzoate, etc.) and the like. .
[0028]
Examples of the surfactant, solubilizer, emulsifier, and solvent include nonionic surfactants such as sucrose fatty acid ester, polyoxyethylene hydrogenated castor oil, polysorbates, and pluronics, ethanol, for injection Examples include distilled water and purified water.
[0029]
Examples of the suspending agent and thickening agent include gum arabic, crystalline cellulose, bee gum, xanthan gum, gelatin, metrose and edible salt thereof, carmellose and edible salt thereof.
Examples of the colorant include caramel, β-carotene, various food colors (food yellow No. 1, food red No. 2, etc.) and the like.
Examples of the stabilizer include an edible salt of edetic acid, sodium chloride, and an edible salt of pyrosulfite.
[0030]
Other ingredients (preservatives, preservatives, flavoring agents, fragrances, cooling agents, surfactants, solubilizers, emulsifiers, solvents, buffering agents, suspending agents, thickeners, colorants, stabilization The content of the agent and the solubilizing agent in the internal liquid composition is not particularly limited, and it is preferably contained as appropriate in the amount blended with the conventional oral liquid.
[0031]
The method for preparing the internal liquid composition is not particularly limited. Usually, each component and a part of a solvent such as purified water are mixed and dissolved, and the remaining solvent is added to prepare a liquid amount. Accordingly, the pH is adjusted using acid or alkali.
[0032]
The internal liquid composition of the present invention may be a pharmaceutical, quasi-drug, or health food that is orally administered in a liquid form, and is a liquid (eg, syrup, drink), suspension, emulsion, granule, powder. And can be formulated into capsules and the like, and can be applied to those used in the form of internal liquid preparations such as nourishing tonics, gastric sensitizers, antipyretic analgesics, bronchodilators and the like.
[0033]
【Example】
EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated further more concretely, this invention is not limited to the following Example at all.
[0034]
[Example 1] Oral solution The ingredients shown in Table 1 below, purified water, polyoxy hydrogenated castor oil, and sodium benzoate were added, and the pH was adjusted to 3.4 with citric acid. The liquid preparations of the present invention products 1-2 and comparative products 1-4 were produced.
[0035]
Next, for each oral solution, 17 items were given by 17 panelists: (1) bitterness / astringency / egg taste, (2) good aftertaste, (3) good taste, and (4) unique discomfort. Sensory evaluation was performed according to the following evaluation criteria, and the average value of the evaluation results was calculated. The results are shown in Table 1.
[0036]
<Evaluation criteria>
5 points: Excellent 4 points: Slightly superior 3 points: Normal 2 points: Slightly inferior 1 point: Inferior [0037]
[Table 1]
[0038]
[Example 2] Oral syrup The ingredients shown in Table 2 below, purified water, polyoxyethylene hydrogenated castor oil, and sodium benzoate are added, and the pH is adjusted to 100 mL with citric acid. The internal syrup of 3-4 and the comparative products 5-7 was manufactured.
[0039]
Next, for each internal syrup, four panelists (1) bitterness / astringency / egg taste, (2) good aftertaste, (3) good pretaste, and (4) unique discomfort by 18 panelists. The sensory evaluation was performed in the same manner as in Example 1, and the average value of the evaluation results was calculated. The results are shown in Table 2.
[0040]
[Table 2]
[0041]
[Example 3] Oral solution The ingredients shown in Table 3 below, polyoxyethylene hydrogenated castor oil, sodium benzoate and purified water were added, and the pH was adjusted to 3.5 with citric acid. As a result, 50 mL of the internal use solution 3 was obtained.
[0042]
[Table 3]
[0043]
[Example 4] Oral solution The ingredients shown in Table 4 below, propylene glycol, sodium benzoate and purified water were added, and the pH was adjusted to 4 with citric acid to obtain 50 mL of the internal solution of Example 4. .
[0044]
[Table 4]
[0045]
[Example 5] Oral solution The ingredients shown in Table 5 below, polyoxyethylene hydrogenated castor oil, sodium benzoate and purified water were added, and the pH was adjusted to 3.2 with citric acid. Thus, 30 mL of the internal solution for 5 was obtained.
[0046]
[Table 5]
[0047]
All of the internal use liquid preparations of Examples 3 to 5 described above were able to be taken deliciously with suppressed unpleasant taste such as the bitter taste of pharmaceutical food active ingredients and unique unpleasant odors.
[0048]
【The invention's effect】
As described above, according to the present invention, even if an internal liquid containing an active ingredient of a pharmaceutical food having an unpleasant taste such as a bitter taste or a unique unpleasant odor is used continuously, it can be taken deliciously and taken by a child. However, an oral liquid composition with an improved taste and odor that does not vomit due to the nasty taste and odor of the internal liquid is obtained.
Claims (5)
(b)フルーツ系香料と、
(c)アセスルファムカリウムとステビア抽出物を、質量比で、アセスルファムカリウム:ステビア抽出物=10:1〜4となるように配合した甘味料と、
を含有することを特徴とする内服液組成物。(A) an active pharmaceutical ingredient having an unpleasant taste and smell;
(B) fruit flavors;
(C) a sweetener prepared by blending acesulfame potassium and stevia extract such that acesulfame potassium: stevia extract = 10: 1 to 4 by mass ratio;
An oral liquid composition comprising:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002027757A JP4190769B2 (en) | 2002-02-05 | 2002-02-05 | Oral liquid composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002027757A JP4190769B2 (en) | 2002-02-05 | 2002-02-05 | Oral liquid composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003231647A JP2003231647A (en) | 2003-08-19 |
| JP4190769B2 true JP4190769B2 (en) | 2008-12-03 |
Family
ID=27773398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002027757A Expired - Fee Related JP4190769B2 (en) | 2002-02-05 | 2002-02-05 | Oral liquid composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4190769B2 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4347161B2 (en) * | 2004-08-20 | 2009-10-21 | キリンフードテック株式会社 | Hop extract-containing composition |
| US8900644B2 (en) * | 2004-12-22 | 2014-12-02 | Colgate-Palmolive Company | Oral care compositions containing compounds from magnolia and hops extracts |
| JP4911278B2 (en) * | 2005-08-29 | 2012-04-04 | 大正製薬株式会社 | Liquid composition |
| US8435588B2 (en) * | 2005-11-23 | 2013-05-07 | The Coca-Cola Company | High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith |
| US8029846B2 (en) * | 2007-03-14 | 2011-10-04 | The Concentrate Manufacturing Company Of Ireland | Beverage products |
| EP2386209A3 (en) | 2010-05-11 | 2012-06-13 | Jungbunzlauer Austria AG | Natural sweetener |
| TW201340998A (en) * | 2012-02-29 | 2013-10-16 | Takeda Pharmaceutical | Oral preparation |
| JP6017249B2 (en) * | 2012-09-28 | 2016-10-26 | 小林製薬株式会社 | Liquid pharmaceutical composition for oral administration |
| JP6862200B2 (en) * | 2017-02-02 | 2021-04-21 | エルメッド株式会社 | A vildagliptin-containing pharmaceutical composition, a method for suppressing the odor of vildagliptin in the pharmaceutical composition, and an agent for suppressing the odor of vildagliptin in the pharmaceutical composition. |
| WO2020175274A1 (en) * | 2019-02-27 | 2020-09-03 | 株式会社ヤクルト本社 | Food/beverage product, off-flavor masking agent for food/beverage product, and off-flavor masking method for food/beverage product |
| KR102483142B1 (en) | 2020-02-28 | 2023-01-04 | 주식회사 종근당 | Multi-vitamins complex composition with improved compliance through size reduction for formulation using iLet(innovative Low excipient tablet) technology and preparation method for the same |
| KR102622231B1 (en) | 2022-07-01 | 2024-01-08 | 주식회사 종근당 | PHARMACEUTICAL COMPOSITION OF MULTI-VITAMINS COMPLEX FOR IMPROVING APPEARANCE STABILITY USING iSTab(innovative Stability Technology by antimoisture barrier) TECHNOLOGY |
-
2002
- 2002-02-05 JP JP2002027757A patent/JP4190769B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003231647A (en) | 2003-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4726269B2 (en) | Oral solution | |
| JP5620647B2 (en) | Sleepiness alarm composition | |
| KR101490721B1 (en) | Liquid Formulation for Deferiprone With Palatable Taste | |
| JP4190769B2 (en) | Oral liquid composition | |
| JP4501024B2 (en) | Composition with reduced bitterness and odor of cysteines | |
| JP2002363105A (en) | Masking method for unpleasant taste and liquid for oral use | |
| JP2004161679A (en) | Liquid for internal use | |
| JP3805646B2 (en) | Pharmaceutical solution | |
| JP4373649B2 (en) | Oral solution | |
| JP4068442B2 (en) | Taste improving composition | |
| JP2003171314A (en) | Oral liquid composition | |
| JP2004175672A (en) | Oral liquid agent containing glycyrrhizinic acid | |
| JP6508671B2 (en) | Composition comprising red pepper extract and / or ginger extract, and method for producing the same | |
| JPH09286724A (en) | Liquid stablizer for oral administration | |
| JPH10167988A (en) | Oral liquid preparation | |
| JP5009707B2 (en) | Solution for oral administration of quinolone antibacterial agent masked with unpleasant taste | |
| JP6686292B2 (en) | Amino acid-containing composition | |
| JPH0827034A (en) | Internal liquid preparation containing erythritol | |
| JP2000226327A (en) | Oral solution | |
| JP4990515B2 (en) | Isosorbide preparation with improved taste quality | |
| JPH1036252A (en) | Belladonna (total) alkaloid-containing oral liquid | |
| JP5298526B2 (en) | Composition for internal use | |
| WO2011148794A1 (en) | Dimemorfan-containing liquid preparation for internal administration | |
| JPH09286723A (en) | Improved oral solution | |
| JP2017508799A (en) | Composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040817 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080520 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080902 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080917 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110926 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4190769 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120926 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120926 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130926 Year of fee payment: 5 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |